<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02856633</url>
  </required_header>
  <id_info>
    <org_study_id>STP-VIT-001</org_study_id>
    <nct_id>NCT02856633</nct_id>
  </id_info>
  <brief_title>Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station</brief_title>
  <official_title>Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cloud DX Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cloud DX Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective is to satisfy the testing requirements for the Qualcomm Tricorder XPRIZE
      Competition. This requires an oversight model using the Vitaliti CVSM Wearable, Vitaliti
      Spirotoscope, and Vitaliti IVD Station to continuously monitor the patient's five core vital
      signs and to detect the health conditions required by the competition.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">February 19, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Successful diagnosis of patient's condition by Vitaliti software as compared to patient's Medical Record</measure>
    <time_frame>90 minutes</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Urinary Tract Infection</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Atrial Fibrillation</condition>
  <condition>OSA</condition>
  <condition>COPD</condition>
  <condition>Pneumonia</condition>
  <condition>Acute Otitis Media</condition>
  <condition>Leukocytosis</condition>
  <condition>Iron Deficient Anemia</condition>
  <condition>Hypertension</condition>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Vitaliti System</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vitaliti</intervention_name>
    <arm_group_label>Vitaliti System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult subjects with urinary tract infection, diabetes mellitus, atrial fibrillation, sleep
        apnea, COPD, pneumonia, acute otitis media, leukocytosis, anemia, or hypertension will be
        recruited to participate in this observational study from Oakville-Trafalgar Memorial
        Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 65 years of age.

          -  English speaking

          -  Established diagnosis of one of the thirteen required conditions with evidence in
             Medical Record.

        Exclusion Criteria:

          -  Lack of patient consent

          -  Has pacemaker or internal medical device

          -  Pregnancy

          -  Concurrent enrollment into a clinical trial that may affect subject treatment

          -  Age less than 18 or over 65

          -  Physical disabilities affecting vision (eyeglasses or contact lenses will be allowed),
             manual manipulation, or use of a computer or mobile device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sonny Kohli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oakville Trafalgar Memorial Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oakville Trafalgar Memorial Hospital</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6M 0L8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2016</study_first_posted>
  <last_update_submitted>May 8, 2017</last_update_submitted>
  <last_update_submitted_qc>May 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
    <mesh_term>Leukocytosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

